Filters

Latest News

2017-02-10 09:30:19

IFPMA launches its 2017 facts & figures report

Geneva, 10 February 2017 – IFPMA has just published its 2017 facts & figures report containing a wealth of data ...

Read More

2017-02-09 14:00:33

Leadership rotation at Fight the Fakes, the worldwide campaign to protect people from fake medicines

Today the International Federation of Pharmaceutical Wholesalers (IFPW) begins its role as secretariat of Fight ...

Read More

2017-02-07 07:54:50

Thomas Cueni takes helm of IFPMA as Director General

Thomas B. Cueni has taken up office as Director General of IFPMA on February 1, ...

Read More

2017-02-03 07:28:55

IFPMA and the IAEA through its Programme of Action for Cancer Therapy (PACT) join forces to make a difference in comprehensive cancer control

The International Federation of Pharmaceutical Manufacturers & Associations (IFPMA) and its members, with an additional ...

Read More

2017-01-18 05:00:23

22 Biopharma Companies Partner and Launch First-of-its-kind Global Initiative to Address Rise of Non-Communicable Diseases

  22 Biopharma Companies Partner and Launch First-of-its-kind Global Initiative to Address Rise of Non-Communicable ...

Read More

2016-11-30 19:06:57

Ian C. Read Elected New President of the International Federation of Pharmaceutical Manufacturers & Associations (IFPMA)

Ian C. Read, Chairman of the Board and Chief Executive Officer, Pfizer, takes over as ...

Read More

2016-11-23 13:25:20

International Federation of Pharmaceutical Manufacturers and Associations (IFPMA) head announces departure

  Geneva, 23 November 2016 – After seven years as Director General, Eduardo Pisani announced ...

Read More

Latest Statement

2017-02-16 08:32:05

G-FINDER Report 2016: The biopharmaceutical industry confirms its status as a significant funder of neglected disease R&D

IFPMA, the international association representing the innovative biopharmaceutical industry, welcomes the G-FINDER 2016[1] results, which shows that industry consolidated its ...

Read More

2017-01-30 12:07:43

WHO EB 140, Item 10.2, Draft global action plan on the public health response to dementia

  Geneva, 23 November 2016 – After seven years as ...

Read More

2017-01-27 18:26:36

WHO EB140 agenda item 8.6 Member State mechanism on substandard/spurious/ falsely-labelled/falsified/counterfeit medical products

  Geneva, 23 November 2016 – After seven years as ...

Read More

2017-01-27 11:20:19

WHO EB 140, Item 7.4, Public Health implications of the implementation of the Nagoya Protocol

  Geneva, 23 November 2016 – After seven years as ...

Read More

2017-01-26 16:25:16

WHO EB 140, Item 8.3, Addressing the global shortage of medicines and vaccines

  Geneva, 23 November 2016 – After seven years as ...

Read More

2017-01-24 15:17:53

IFPMA statement on the entry in force of the TRIPS “Paragraph 6” amendment

  Geneva, 23 November 2016 – After seven years as ...

Read More

2017-01-20 10:05:31

IFPMA supports the Coalition for Epidemic Preparedness Innovation launched at WEF17 in Davos

  Geneva, 23 November 2016 – After seven years as ...

Read More

mailto:s.kaenzig@ifpma.org +41 22 338 32 49
direct line
Twitter skaenzig

Sadia Kaenzig - Communications Manager

Sadia manages communications on issues including regulatory, intellectual property protection, trade and the economic footprint of the research-based pharmaceutical industry, research and development ecosystem and innovation, vaccines including influenza vaccines, and biotherapeutics.

mailto:m.depol@ifpma.org +41 22 338 32 20
direct line
Twitter @MorganePol

Morgane De Pol - Communications and Public Affairs

Morgane manages communications on issues including the research-based pharmaceutical industry’s commitment to achieving sustainable and inclusive development, advancing Universal Health Coverage, designing transformational partnerships to build healthier societies, boosting innovation for neglected tropical diseases, expanding access to high quality treatments for infectious and chronic diseases, fighting counterfeit medicines, and promoting resilient and efficient health systems.

A shared commitment to global health

Our Brouchure

2015 Edition

A shared commitment to global health

At IFPMA we advocate policies and practices that encourage the discovery of and access to life-saving and life-enhancing medicines and vaccines, for people everywhere.


Our Logo

Full colour EPS format

Our Logo

Full colour PNG format


FULL Name LOGO

Full colour EPS format


FULL Name LOGO

Full colour PNG format

Hot Topic

Pharmacovigilance: Do your bit, play your part!

Pharmacovigilance is one of the key steps to ensuring the safety of all our medicines, including biotherapeutics and vaccines. It encourages an ongoing cycle of communication between patients, health professionals, regulatory authorities, and our biopharma industry which is

Read More

Interview

IFPMA 2015 interview series 'Biodiversity, human health, and pharma'

A must-watch: Dr Manisha A. Desai, assistant general patent counsel at Eli Lilly and Company, gives her take on the importance of the Convention of Biodiversity and the Nagoya Protocol for the pharma industry. What's key is to

Read More

Our Blog

Latest Tweets

How @UNESCO is boosting #STEM education for girls & young women in Africa: https://t.co/lJA3gwoNrC @SciDevNetSSA
  @IFPMA
RT @gatesfoundation: Stunning gains in the last 25 years are proof that the best investment any of us can make is in the lives of others. h…
52
  @IFPMA
.@WHO praises India for its launch of one of the world’s largest #immunization campaign against measles & rubella https://t.co/3l2Uktm3Jl
  @IFPMA
How is misuse of #antibiotics contributing to #antimicrobialresistance? Check out this infographic from @WBG_Healthhttps://t.co/rVVFj5bbqO
4
  @IFPMA
RT @EFPIA: Nathalie Moll announced as new EFPIA Director General, starting in April 2017 https://t.co/iLsvi3uDz8
26
  @IFPMA